215 related articles for article (PubMed ID: 16832815)
1. Role of angiogenesis in chronic lymphocytic leukemia.
Letilovic T; Vrhovac R; Verstovsek S; Jaksic B; Ferrajoli A
Cancer; 2006 Sep; 107(5):925-34. PubMed ID: 16832815
[TBL] [Abstract][Full Text] [Related]
2. The clinical and biologic importance of neovascularization and angiogenic signaling pathways in chronic lymphocytic leukemia.
Shanafelt TD; Kay NE
Semin Oncol; 2006 Apr; 33(2):174-85. PubMed ID: 16616064
[TBL] [Abstract][Full Text] [Related]
3. Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF.
Maffei R; Martinelli S; Castelli I; Santachiara R; Zucchini P; Fontana M; Fiorcari S; Bonacorsi G; Ilariucci F; Torelli G; Marasca R
Leuk Res; 2010 Mar; 34(3):312-21. PubMed ID: 19616847
[TBL] [Abstract][Full Text] [Related]
4. [Clinical importance of angiogenesis and angiogenic factors in oncohematology].
Grosicki S; Grosicka A; Hołowiecki J
Wiad Lek; 2007; 60(1-2):39-46. PubMed ID: 17607967
[TBL] [Abstract][Full Text] [Related]
5. [Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) are elevated in peripheral blood plasma of patients with chronic lymphocytic leukemia and decrease after intensive fludarabine-based treatment].
Smolej L; Andrýs C; Krejsek J; Belada DZ; Zák P; Siroký O; Malý J
Vnitr Lek; 2007 Nov; 53(11):1171-6. PubMed ID: 18277626
[TBL] [Abstract][Full Text] [Related]
6. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
Smolej L; Kasparová P
APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic factors in chronic lymphocytic leukemia.
Xia Y; Lu RN; Li J
Leuk Res; 2012 Oct; 36(10):1211-7. PubMed ID: 22727510
[TBL] [Abstract][Full Text] [Related]
8. Malignant hematopoietic cells induce an increased expression of VEGFR-1 and VEGFR-3 on bone marrow endothelial cells via AKT and mTOR signalling pathways.
Mirshahi P; Toprak SK; Faussat AM; Dubrulle S; Marie JP; Soria C; Soria J; Mirshahi M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1003-10. PubMed ID: 16959214
[TBL] [Abstract][Full Text] [Related]
9. [Angiogenesis and hematological malignancies].
Iversen PO
Tidsskr Nor Laegeforen; 2003 Nov; 123(22):3198-200. PubMed ID: 14714007
[TBL] [Abstract][Full Text] [Related]
10. Markers of increased angiogenesis and their correlation with biological parameters identifying high-risk patients in early B-cell chronic lymphocytic leukemia.
Molica S; Cutrona G; Vitelli G; Mirabelli R; Molica M; Digiesi G; Ribatti D; Ferrarini M; Vacca A
Leuk Res; 2007 Nov; 31(11):1575-8. PubMed ID: 17485110
[TBL] [Abstract][Full Text] [Related]
11. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
12. Angiogenic factors in chronic lymphocytic leukaemia (CLL): Where do we stand?
Aguirre Palma LM; Gehrke I; Kreuzer KA
Crit Rev Oncol Hematol; 2015 Mar; 93(3):225-36. PubMed ID: 25459668
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis in hematologic malignancies.
Moehler TM; Neben K; Ho AD; Goldschmidt H
Ann Hematol; 2001 Dec; 80(12):695-705. PubMed ID: 11797109
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis, angiogenic factor expression and hematological malignancies.
Ribatti D; Vacca A; De Falco G; Roccaro A; Roncali L; Dammacco F
Anticancer Res; 2001; 21(6B):4333-9. PubMed ID: 11908688
[TBL] [Abstract][Full Text] [Related]
15. [Angiotensin and its mediators. Their pathogenic and clinical significance in "angiogenic diseases"].
Szekanecz Z; Bordán E; Szabó Z; Szegedi G
Orv Hetil; 1998 Feb; 139(5):227-34. PubMed ID: 9489376
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis and gliomas: current issues and development of surrogate markers.
Jouanneau E
Neurosurgery; 2008 Jan; 62(1):31-50; discussion 50-2. PubMed ID: 18300890
[TBL] [Abstract][Full Text] [Related]
17. Angiogenesis in acute and chronic lymphocytic leukemia.
Molica S; Vacca A; Levato D; Merchionne F; Ribatti D
Leuk Res; 2004 Apr; 28(4):321-4. PubMed ID: 15109528
[TBL] [Abstract][Full Text] [Related]
18. Modulation of angiogenesis in patients with myelodysplastic syndrome.
Estey EH
Best Pract Res Clin Haematol; 2004 Dec; 17(4):623-39. PubMed ID: 15494299
[TBL] [Abstract][Full Text] [Related]
19. Current insights on the biology and clinical aspects of VEGF regulation.
Birk DM; Barbato J; Mureebe L; Chaer RA
Vasc Endovascular Surg; 2008 Dec-2009 Jan; 42(6):517-30. PubMed ID: 18799497
[TBL] [Abstract][Full Text] [Related]
20. [Angiogenesis in the bone marrow of patients with chronic lymphocytic leukaemia].
Kasparová P; Smolej L
Cesk Patol; 2007 Apr; 43(2):50-8. PubMed ID: 17623976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
